Whatsapp

Denoci 120mg Injection contains a medication called Denosumab Its primary purpose is to treat osteoporosis a condition characterized by the thinning and weakening of bones However it is important to note that this medication is not suitable for individuals under the age of 18 particularly adolescents and children It is also not recommended for individuals with low blood calcium levels While undergoing treatment with Denoci 120mg Injection it is advised to also take supplements of vitamin D and calcium Your doctor will provide you with detailed information and discuss the importance of these supplements It is crucial to have a conversation with your doctor before starting Denoci 120mg Injection if you have a history of thyroid or parathyroid surgery kidney problems kidney dialysis malabsorption syndrome trouble absorbing minerals in your stomach or intestines or if you are planning to undergo dental surgery or have your teeth removed The medication works by reducing bone resorption which is the process where osteoclasts break down bone tissue and release calcium into the blood Denosumab inhibits the formation and function of osteoclasts thereby increasing bone mass and strength

halth-assessment-tools

Available in 3 variations

thumbnail.svg

Denoci 120mg injection 1.7ml

Denoci 120mg injection 1.7ml

Denosumab (120mg)

vial of 1.7 ml injection

thumbnail.svg

Denoci OP Injection 1ml

Denoci OP Injection 1ml

Denosumab (60mg)

prefilled syringe of 1 ml Injection

thumbnail.svg

Denoci 60mg Injection liquid 1ml

Denoci 60mg Injection liquid 1ml

Denosumab (60mg)

prefilled syringe of 1 ml Injection

Written By:

about-us.jpg

Published At: Dec 10, 2024

Updated At: Dec 26, 2024

Reviewed By:

about-us.jpg

Published At: Dec 10, 2024

Updated At: Dec 26, 2024

Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.